Safety and Immunogenicity of the Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Children Aged 3 to 8 Years
Latest Information Update: 02 Sep 2014
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 30 Aug 2014 According to the European Clinical Trials Database record, status changed from recruiting to completed.
- 25 Jun 2013 New trial record